Skip to content

A Registry Study of 100 Thousand Cases of Pediatric Patients on Reduning Injection(a Chinese Medicine Injection)Used in Hospitals in China

A Study of 100 Thousand Cases of Pediatric Patients of Clinical Safety Monitoring and Characteristic Observation and the Mechanism of Anaphylactic Reaction Used Reduning(a Chinese Medicine Injection)in Hospitals in China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03461692
Enrollment
100000
Registered
2018-03-12
Start date
2018-03-10
Completion date
2018-12-31
Last updated
2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Tracheobronchitis, Upper Respiratory Tract Infection

Brief summary

This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences in February 2018. The purpose of this study is to make a monitoring of adverse reactions in 100 thousand children aged 14 years and below to see whether Reduning injection is safe and the characteristic and mechanism of anaphylactic reaction used Reduning injection in hospitals in China.

Detailed description

In order to observe the clinical characteristics and adverse reactions of patients aged 14 and below using Reduning injection in hospital,registry study is suitable method in this area. Otherwise, nested case control study is used to find out the mechanism of anaphylaxis. Calculating the incidence of adverse drug reactions is one of the main aims for this study. 100000 cases need to be registered at least. The aim population is who using Reduning injection from February 2018 to December 2018.

Interventions

DRUGpatients under 14 years of age using Reduning injeciton

To assess in patients using Reduning injection's clinical features and drug adverse reaction during patients' hospital stay. The registry procedure will only for patients under 14 years of age using Reduning injection,observed from February 2018 to December 2018.

Sponsors

Children's Hospital of Nanjing Medical University
CollaboratorOTHER
Hunan University of Traditional Chinese Medicine
CollaboratorOTHER
Qilu Children's Hospital of Shandong University
CollaboratorOTHER
Zhengzhou Children's Hospital, China
CollaboratorOTHER
China Academy of Chinese Medical Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 14 Years
Healthy volunteers
No

Inclusion criteria

Patients aged 14 and below using Reduning injection from February 2018 to December 2018.

Exclusion criteria

None

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Adverse Drug Reaction3 daysIncidence of Reduning Injection'Adverse Drug Reaction(ADRs)and Identify Factors That Contributed to the Occurrence of the Adverse Drug Reaction

Secondary

MeasureTime frameDescription
The Ratio of Body Temperature to Normal3 daysThe Ratio of Body Temperature to Normal(Lower Than 37.3ºC)
The Ratio of WBC to Normal3 daysThe Ratio of Body Temperature to Normal(Within the Range of (4 to 10) x the 9 square of 10/L)
The Ratio of The Antibiotic Used3 daysCalculating The Ratio of Patients Using Antibiotics Accounted for All Patients Using Reduning Injection.

Contacts

Primary ContactYanming Xie, BA
datamining5288@163.com86-13911112416
Backup ContactLianxin Wang, doctor
wanglianxin_tcm@126.com86-13521781839

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026